Coya Therapeutics, Inc. (COYA) stock
COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.09+0.07 (+2.32%)
Close on Nov 18, 2026Market cap $72.48MP/E –Yield –
Coya Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Coya Therapeutics's market cap was $75.30M on Nov 11, 2026, against $108.99M a year earlier. Over the last 4 years it ranged from $10.29M to $142.90M, with a median of $95.33M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $75.30M | -22.5% |
| 2025 | Dec 31, 2025 | $97.11M | +11.3% |
| 2024 | Dec 31, 2024 | $87.22M | +18.3% |
| 2023 | Dec 29, 2023 | $73.71M | +500.7% |
| 2022 | Dec 30, 2022 | $12.27M | – |
See a number that looks wrong?